Your shopping cart is currently empty

ITGB3-IN-1 is an orally active integrin β3 subunit (ITGB3) inhibitor with a Kd of 7.26 μM. This compound demonstrates potent anti-orthopoxvirus activity, exhibiting an EC50 of 1.82 μM against vaccinia virus (VACV). ITGB3-IN-1 also inhibits hERG with an IC50 of 1.13 μM and can be utilized in orthopoxvirus research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | ITGB3-IN-1 is an orally active integrin β3 subunit (ITGB3) inhibitor with a Kd of 7.26 μM. This compound demonstrates potent anti-orthopoxvirus activity, exhibiting an EC50 of 1.82 μM against vaccinia virus (VACV). ITGB3-IN-1 also inhibits hERG with an IC50 of 1.13 μM and can be utilized in orthopoxvirus research. |
| In vitro | ITGB3-IN-1 (Compound 6) exhibits low cytotoxicity in Vero cells (CC₅₀ = 400 μM) and has a high therapeutic index against vaccinia virus (219.78). |
| In vivo | ITGB3-IN-1 (Compound 6) demonstrates potent anti-vaccinia virus activity in mice when administered orally at a dosage of 45-90 mg/kg once daily for five days. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.